Santhera Pharmaceuticals Stock Forward View
| SANN Stock | CHF 15.46 0.72 4.88% |
This page provides Naive Prediction reference data for Santhera Pharmaceuticals Holding, calculated from historical daily prices. The model output shown here is derived from Santhera Pharmaceuticals's historical price series and is provided for informational purposes. Projected values and accuracy measures are included for reference.
The Naive Prediction forecasted value of Santhera Pharmaceuticals Holding on the next trading day is expected to be 16.19 with a mean absolute deviation of 0.55 and the sum of the absolute errors of 34.01.This model is not at all useful as a medium-long range forecasting tool of Santhera Pharmaceuticals Holding. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Santhera Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights. The Naive Prediction reference information for Santhera Pharmaceuticals is based on available price data and is intended for informational purposes. Naive Prediction Price Forecast For the 27th of March
Given 90 days horizon, the Naive Prediction forecasted value of Santhera Pharmaceuticals Holding on the next trading day is expected to be 16.19 with a mean absolute deviation of 0.55 , mean absolute percentage error of 0.45 , and the sum of the absolute errors of 34.01 .Please note that although there have been many attempts to predict Santhera Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Santhera Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Santhera Pharmaceuticals | Santhera Pharmaceuticals Price Prediction | Research Analysis |
Forecasted Value
For the next trading day, Macroaxis evaluates Santhera Pharmaceuticals' predictive range by looking for statistically meaningful downside and upside boundaries. At the moment, the model places downside around 12.44 and upside around 19.93 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Santhera Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Santhera Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.1576 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.5485 |
| MAPE | Mean absolute percentage error | 0.0385 |
| SAE | Sum of the absolute errors | 34.0095 |
Other Forecasting Options for Santhera Pharmaceuticals
The autocorrelation structure of Santhera Pharmaceuticals' daily returns reveals whether Santhera exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements helps distinguish persistent directional moves from temporary noise in Santhera Stock price data. Stochastic oscillator analysis compares Santhera Pharmaceuticals' closing price to its range over a given period.Santhera Pharmaceuticals Related Equities
These firms work in a similar space as Santhera Pharmaceuticals within the Health Care space and serve as useful points for comparison. Return on equity across these peers shows how well each firm turns capital into profit. When Santhera Pharmaceuticals breaks from its peer group on a key metric, it often signals a firm-level change worth exploring. This type of review is most useful when done often to track how positions shift over time.
| Risk & Return | Correlation |
Santhera Pharmaceuticals Market Strength Events
Market strength indicators applied to Santhera Pharmaceuticals stock help assess momentum and resilience across environments. These indicators support informed market timing decisions when analyzing Santhera Pharmaceuticals. For Santhera Pharmaceuticals Holding, market strength indicators complement fundamental analysis with timing context.
Santhera Pharmaceuticals Risk Indicators
Risk indicator analysis for Santhera Pharmaceuticals is essential for accurately projecting its future price trajectory. The process involves identifying the amount of risk involved in Santhera Pharmaceuticals' investment and either accepting or mitigating it. Understanding the risk profile of Santhera Pharmaceuticals' allows investors to make more informed decisions about position sizing.
| Mean Deviation | 2.84 | |||
| Semi Deviation | 2.96 | |||
| Standard Deviation | 3.64 | |||
| Variance | 13.28 | |||
| Downside Variance | 10.67 | |||
| Semi Variance | 8.74 | |||
| Expected Short fall | -3.41 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Santhera Pharmaceuticals
A coverage review of Santhera Pharmaceuticals Holding shows when the security is attracting above-average attention from contributors and market observers. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
Santhera Pharmaceuticals Short Properties
Short sentiment tied to Santhera Pharmaceuticals Holding matters because heavier bearish pressure can change how quickly future price expectations become unstable. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 11.4 M | |
| Cash And Short Term Investments | 40.9 M |
Additional Tools for Santhera Stock Analysis
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |